Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
ASSESS Patient has ocular hypertension of >24 mm Hg, and family history of glaucoma. Patient wants to know if POAG can be prevented? Question of Therapy/Prevention 60 year old patient with myopia, family history of glaucoma, and cardiovascular disease. Patient wants to know what tests should be done? Question of Diagnosis ASK (PICO) P In a patient with ocular hypertension (IOP) I would therapy with timolol C versus no treatment O decrease the risk of developing glaucoma? P In a patient with conditions associated with increased risk for glaucoma I would frequency-doubling technology (FDT) perimetry C be more effective than Damato campimetry O to screen for glaucoma? P In a patient with wet macular degeneration I is Avastin C as effective as Lucentis O in improving visual acuity? ACQUIRE (4 S) 1. Dynamed 2. ACP PIER 3. Cochrane DSR or other systematic review 4. Ovid MEDLINE APPRAISE Randomized Controlled Trial Filter (Level of Evidence, e.g., A-C, 1-3, etc.) 1. Dynamed 2. ACP PIER 3. Cochrane DSR or other systematic review 4. Ovid MEDLINE Prospective Cohort Study Blind comparison to gold standard Filter (Level of Evidence, e.g., A-C, 1-3, etc.) Patient is a retired teacher and has 1. Dynamed Randomized Controlled Trial wet macular degeneration. He is 2. ACP PIER Filter (Level of Evidence, e.g., concerned about the cost of the 3. Cochrane DSR or other A-C, 1-3, etc.) treatment, Lucentis, that you have systematic review recommended. Is there a more cost 4. Ovid MEDLINE effective alternative? Question of Therapy Patient is a broadcast news reporter, P In a patient with dry eye syndrome 1. Dynamed Randomized Controlled Trial wears contacts, and has dry eye I are omega-3 or omega-6 fatty acids 2. ACP PIER Filter (Level of Evidence, e.g., syndrome. Eye drops have not effective 3. Cochrane DSR or other A-C, 1-3, etc.) helped and she wants to know if C versus no treatment systematic review omega fatty acid supplements might O in relieving dryness? 4. Ovid MEDLINE relieve her symptoms. Question of Therapy Patient has Fuch’s dystrophy with P In a patient with early Fuch’s dystrophy 1. Dynamed Cohort, Case Control, Case central corneal guttae and no I at what stage is corneal transplantation 2. ACP PIER Series edema. She is 37 years old and C none 3. Cochrane DSR or other Filter (Level of Evidence, e.g., wants to know how soon she might O indicated for vision loss? systematic review A-C, 1-3, etc.) need surgery. Question of 4. Ovid MEDLINE Prognosis Evidence Based Retrieval and Appraisal Worksheet – OPT 6162. Sandra Martin, M.L.I.S., Lecture 11/22/10 APPLY Can the results be used in care of this patient?